Vulvovaginal Candidiasis Clinical Trials

45 clinical trials for Vulvovaginal Candidiasis across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis — RECRUITING · NA
• Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome — RECRUITING · PHASE1
• Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC) — RECRUITING · NA
• Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis — RECRUITING · PHASE2
• Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis — RECRUITING · NA
• Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes — RECRUITING
• Comparative Performance of a Vaginal Yeast Test — RECRUITING
• A phase IIa clinical trial in patients with vaginal mycosis to evaluate clinical efficacy, safety and tolerability and dose response relationship of topically administered ProF-001. — COMPLETED · PHASE2
• DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy — ACTIVE_NOT_RECRUITING
• Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis — ACTIVE_NOT_RECRUITING · PHASE3
• Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis — COMPLETED · NA
• Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment — NOT_YET_RECRUITING · NA
• An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group — ACTIVE_NOT_RECRUITING · NA
• Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis — COMPLETED · NA
• Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp — COMPLETED · PHASE1
• Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis — COMPLETED · NA
• Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC） — NOT_YET_RECRUITING
• Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis — COMPLETED · PHASE3
• Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection — OTHER · PHASE1
• A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations — COMPLETED · NA
• Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis. — OTHER · NA
• Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms — COMPLETED · NA
• VVC Sampling Study for Analysis Validation — COMPLETED
• Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. — WITHDRAWN · PHASE2
• Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis — COMPLETED · NA
• Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis — OTHER · NA
• The Study Of Fluconazole For Vulvovaginal Candidiasis — COMPLETED · PHASE3
• Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis — COMPLETED · PHASE4
• Comparison of Boric Acid vs. Terconazole in Treatment of RVVC — OTHER · NA
• Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis — COMPLETED · PHASE2
• ProF-001_Phase IIa — COMPLETED · PHASE2
• Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis — WITHDRAWN · PHASE3
• Patients With Vulvovaginal Candidiasis — OTHER · PHASE1
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VT-1161 ORAL CAPSULES IN THE TREATMENT OF SUBJECTS WITH RECURRENT VULVOVAGINAL CANDIDIASIS — COMPLETED · PHASE3
• Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis — COMPLETED · PHASE1
• TOL-463 Phase 2 Study for Vaginitis — COMPLETED · PHASE2
• Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) — COMPLETED · NA
• Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis — COMPLETED · PHASE4
• Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis — COMPLETED
• Comparative Efficacy of Ovule vs Tablet — COMPLETED · PHASE3
• Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women — COMPLETED · PHASE1
• Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment — COMPLETED · PHASE2
• MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis — COMPLETED · PHASE2
• Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina — COMPLETED · PHASE4
• Diabetes Mellitus and Vulvovaginal Candidiasis — COMPLETED · PHASE3

Refine this search